O Alternativă Plină de Speranță: Terapia cu Esketamină Intranazală la un Pacient cu Depresie Rezistentă la Tratament - O Descriere de Caz

This case report describes the use of intranasal esketamine, a FDA-approved medication, in treating a patient with treatment-resistant depression who had not responded to at least two adequate antidepressant trials. The report presents esketamine as a therapeutic option for the subset of depressed patients who fail conventional antidepressant treatments.